Deputy Division Director
US FDA
Silver Spring, Maryland, United States
Nonclinical Immunotoxicity Assessment: State of the Science and Future Directions (CE7)
Sunday, November 17, 2024
1:00 PM – 4:30 PM CT
Assessing Dermal Sensitization in a Topical Pharmaceutical (CE7-4)
Sunday, November 17, 2024
3:00 PM – 3:30 PM CT